FDA Wants Big Warning on GlaxoSmithKline Diabetes Drug
NEW YORK (Reuters) - Food and Drug Administration officials are pushing for a "black box" warning on GlaxoSmithKline Plc's hard-hit diabetes drug Avandia, the Wall Street Journal reported, citing sources.